Affiliation:
1. Department of Pulmonary Medicine and Tuberculosis, The Third People’s Hospital of Shenzhen, China.
Publisher
International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine
Reference14 articles.
1. 1. World Health Organization. Global Tuberculosis Report 2021. https://www.who.int/publications/i/item/9789240037021 (accessed March 17, 2022).
2. 2. Mirzayev F, Viney K, Linh NN, Gonzalez-Angulo L, Gegia M, Jaramillo E, Zignol M, Kasaeva T. World Health Organization recommendations on the treatment of drugresistant tuberculosis, 2020 update. Eur Respir J. 2021; 57:2003300.
3. 3. Shoen C, DeStefano M, Hafkin B, Cynamon M. In vitro and in vivo activities of contezolid (MRX-I) against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2018; 62:e00493-18.
4. 4. Hoy SM. Contezolid: First approval. Drugs. 2021; 81:1587-1591.
5. 5. Foti C, Piperno A, Scala A, Giuffrè O. Oxazolidinone asntibiotics: Chemical, biological and analytical aspects. Molecules. 2021; 26:4280.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献